Influence on the behavior of lung cancer H1299 cells by silencing SLC35F2 expression

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Li, Xiao ^a   Li, Jilun ^a   Jiang, Guanchao ^a   Bu, Liang ^a   Yang, Fan ^a   Liu, Jun ^a   Wang, Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Lnvasion; Lung carcinoma; Migration; RNA interference; SLC35F2

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; LENTIVIRUS VECTOR; LIPOSOME; PROTEOGLYCAN; SMALL INTERFERING RNA; SOLUTE CARRIER FAMILY 35 MEMBER F2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 84880334627     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-73     Document Type: Article

References (13)

1. Stankovic T, Byrd PJ, Cooper PR, McConville CM, Munroe DJ, Riley JH, Watts GD, Ambrose H, McGuire G, Smith AD, Sutcliffe A, Mills T, Taylor AM. Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genes. Genomics 1997, 40:265-276.
2. Bangsow T, Baumann E, Bangsow C, Jaeger MH, Pelzer B, Gruhn P, Wolf S, Von Melchner H, Stanimirovic DB. The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier. J Cereb Blood Flow Metab 2008, 28:1249-1260. 10.1038/jcbfm.2008.19, 18382472.
3. Nishimura M, Suzuki S, Satoh T, Naito S. Tissue-specific mRNA expression profiles of human solute carrier 35 transporters. Drug Metab Pharmacokinet 2009, 24:91-99. 10.2133/dmpk.24.91, 19252338.
4. Shen CY, Zhao H, Wang DL, Jiang GC, Wang J, Zhang GL. Molecular cloning, identification and analysis of lung squamous cell carcinoma-related genes. Lung Cancer 2002, 67:235-241.
5. Jiang GC, Bu L, Wang J, Liu J. Preparation of the polyclonal antibody against human SLC35F2 and detection of the expression of SLC35F2 in non-smalI cell lung cancer. Chin J Exp Surg 2009, 26:1046-1048.
6. Bu L, Jiang G, Yang F, Liu J, Wang J. Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging. Mol Med Rep 2011, 4:1289-1293.
7. Huang YQ, Li X, Chen KZ, Chen YT, Yang F, Jiang GC, Liu J, Wang J. Construction and Identification of RNAi Recombinant Lentiviral Vector of Lung Cancer Related Gene SLC35F2. Chin J Exp Surg 2011, 28:419-421.
8. Ishida N, Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch 2004, 447:768-775. 10.1007/s00424-003-1093-0, 12759756.
9. Kumamoto K, Goto Y, Sekikawa K, Takenoshita S, Ishida N, Kawakita M, Kannagi R. Increased expression of UDP galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants. Cancer Res 2001, 61:4620-4627.
10. Ishida N, Kuba T, Aoki K, Miyatake S, Kawakita M, Sanai Y. Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transport family. Genomics 2005, 85:106-116. 10.1016/j.ygeno.2004.09.010, 15607426.
11. Muraoka M, Kawakita M, Ishida N. Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity. FEBS Lett 2001, 495:87-93. 10.1016/S0014-5793(01)02358-4, 11322953.
12. Kamiyama S, Sasaki N, Goda E, Ui-Tei K, Saigo K, Narimatsu H, Jigami Y, Kannagi R, Irimura T, Nishihara S. Molecular cloning and characterization of a novel 3'-phosphoadenosine 5'-phosphosulfate transporter, PAPST2. J Biol Chem 2006, 281:10945-10953. 10.1074/jbc.M508991200, 16492677.
13. Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, Ichikawa Y, Endo I, Kunisaki C, Suzuki H, Hayasizaki Y, Shimada H. Predicting 5-fluorouracil chemo-sensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer 2006, 119:406-413. 10.1002/ijc.21843, 16477629.